Unichem Laboratories Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
UNICHEMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Unichem Laboratories announced the results of its postal ballot concluded on 27 March 2026, with all three resolutions passing with overwhelming shareholder support (99.99% in favour). Resolution 1 (Special) approved the appointment of Dr. (Ms) Swati Patankar (DIN 06594600) as Non-Executive Independent Director for a five-year term effective 5 February 2026. Resolutions 2 and 3 (both Ordinary) approved material related party transactions involving Ipca Laboratories (the holding company with ~70% stake) and Unichem Pharmaceuticals USA Inc., Unichem's wholly owned US subsidiary. The promoter group abstained from voting on Resolutions 2 and 3 as an interested party, with institutional and non-institutional public shareholders voting near-unanimously in favour. Of 7.04 crore total shares, about 80.5% participated in voting for Resolution 1, and ~10.3% for the related party resolutions.
This is largely a procedural compliance update with no negative signals. The appointment strengthens the board with a new independent director, and the related party transactions are now formally approved, reducing future governance friction. The 70% promoter holding by Ipca means their related-party dealings remain a key area for minority shareholders to monitor, though current voting patterns show broad institutional support.